Christopher Clayton in Scottsboro, Alabama

Medical School: University Of Alabama School Of Medicine
Graduation Year: 2010
The Primary Medical Specialty for Christopher Clayton is listed as: Family Practice
Approximate Years of Experience: 14
PAC (PECOS ID)#: 6406095447
NPI #: 1205154127
NPI Created On: 05/17/2010
NPI Last Updated Listed as: 07/05/2013
Primary Taxonomy Code: 207Q00000X
License Number:
MD.31463
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Aspiration and/or injection of large joint or joint capsule
2. Insertion of needle into vein for collection of blood sample
3. Removal of impact ear wax, one ear
4. Automated urinalysis test
5. Urine microalbumin (protein) analysis
6. Hemoglobin a1c level
7. Detection test for influenza virus
8. Pneumococcal vaccine for injection into muscle
9. Vaccine for influenza for administration into muscle, 0.5 ml dosage
10. Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage
11. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
12. Routine ekg using at least 12 leads including interpretation and report
13. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
14. New patient office or other outpatient visit, typically 30 minutes
15. Established patient office or other outpatient visit, typically 15 minutes
16. Established patient office or other outpatient, visit typically 25 minutes
17. Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes
18. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
19. Advance care planning by the physician or other qualified health care professional
20. Administration of influenza virus vaccine